Opendata, web and dolomites


Improving DNA Analysis for Correct Healthcare

Total Cost €


EC-Contrib. €






 IMPACT project word cloud

Explore the words cloud of the IMPACT project. It provides you a very rough idea of what is the project "IMPACT" about.

scientists    complexity    instrument    aggregated    families    amount    bioinformatics    bigger    biological    disorders    genetics    retrieve    market    shortcomings    profitability    strive    return    selling    samplix    opposed    core    diagnosis    millions    bulk    biology    revenue    droplet    despite    multibillion    tumour    trade    drug    reaction    microfluidics    molecule    providers    medical    subscription    gt    place    freedom    strategy    barriers    molecular    musd    encompasses    2019    proprietary    generation    put    personalized    blade    round    chamber    globe    healthcare    team    immunological    sales    dna    estate    revolutionized    over    droplets    preparation    cancer    total    molecules    agreements    biopsies    qualify    resolution    site    operate    razor    launch    capital    single    raised    financing    2018    free    consumables    diseases    oem    minute    commercial    mental    brings    subsequent    full    overcome    engaged    xdrop    patent    plan    sequencing    material    installing    constituting   

Project "IMPACT" data sheet

The following table provides information about the project.


Organization address
address: MILEPARKEN 28
city: HERLEV
postcode: 2730
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 2˙669˙623 €
 EC max contribution 1˙868˙736 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAMPLIX ApS DK (HERLEV) coordinator 1˙868˙736.00


 Project objective

Over the past 10 years DNA sequencing has revolutionized how we apply genetics in personalized healthcare, diagnosis and drug development despite that the sequencing technology comes with numerous shortcomings. Samplix has developed a proprietary technology, Xdrop™, which addresses these shortcomings. Samplix’ technology encompasses state of the art microfluidics, molecular biology and bioinformatics. The Xdrop technology enables scientists and medical personnel to retrieve specific single DNA molecules from a minute amount of biological sample e.g. tumour biopsies, for subsequent DNA sequencing. At the core of the Xdrop technology is the generation of millions of droplets, each droplet constituting a reaction chamber for the sample preparation of single DNA molecules. This is opposed to today’s technology which is based on bulk preparation of sample material for DNA sequencing. Single molecule resolution is key to understanding the complexity of major diseases such as cancer, immunological diseases, mental disorders, etc. The proposed project addresses the need to qualify known market barriers and put measures in place to overcome such market barriers. Samplix has engaged a very experienced management team with an aggregated experience of >50 years in developing and selling products for DNA analysis. Samplix has already established: • 5 test site agreements with leading DNA institutions around the globe • Agreements with leading OEM providers on instrument and consumables • A patent estate of 5 patent families. • Freedom to operate in multibillion € market. At Samplix, we strive at 100 mUSD in revenue and profitability in year five after full commercial launch. To achieve such an ambitious goal, we plan to apply a razor/razor blade sales strategy by installing the instrument “for free” in return for a subscription to consumables Samplix raised 4,5 m€ in May 2018 which brings the total capital raised to 8 m€. A bigger financing round is planned for 2019.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPACT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMPACT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TalentVision (2019)


Read More  

Cancersensing (2019)

A multi-cancer screening platform for fast and accurate early stage cancer detection from urine samples

Read More  

TANDEM (2019)

Tuneable Acoustic Noise DampEning Material

Read More